Clinical Trial

Neuropsychological Evaluation in Intellectual Disability (ENDI)

Study acronym: ENDI
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to evaluate the acceptability ofpatients with trisomy 21 (T21) to perform the full battery of ENDI neurospychological tests and each of the subsets. In this study, three types of population will be recruted : normotypic volunteers, patients with Intellectual Disability and patients T21carriers. This study is separated into 2 phases : * A the preliminary phase : this phase will be used to evaluate subtest design, ergonomics and understanding of instructions, and to identify any malfunctions. The observations gathered will enable the principal investigator to refine the digital design of the battery in collaboration with the publishing company. In this phase, normotypical volunteers and patients with intellectual disabilities will be recruted to perform ENDI test battery. * A main phase : this phase will enable to answer to the main objective. in this phase, patients with Trisomy 21 aged between 25 and 65 will be recruted to perform ENDI test battery.
Trial Details
NCT Number NCT07047963
Lead Sponsor Central Hospital, Nancy, France
Conditions Down Syndrome (Trisomy 21), Neuropsychology, Cognitive Aging, Alzheimer Disease, Alzheimer Disease, Early Onset
Enrollment 40 participants
Start Date 2025-07-01
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-02